Introduction
Recombinant adenoviral vectors are being used as gene delivery vectors in a variety of gene therapy strategies. While the efficient transduction of many different human tissues is on the one hand an important attribute of adenoviral vectors, this promiscuous tropism represents, on the other hand, a limiting feature for their use in gene therapy. In vivo delivery of adenoviral vectors yields efficient transduction of cells that may not be a target for the therapy, most notably liver cells. 1, 2 Because of this vector sequestration by non-target cells, high vector doses are needed for effective gene delivery into target cells. This imposes an increased risk for unwanted sideeffects of the gene therapy procedure, by direct toxicity or host immune responses against the vector. Therefore, adenoviral vectors could potentially be much improved if specific gene transfer into only the desired target cells is accomplished.
The primary high-affinity binding of adenovirus to the host cell surface is mediated by the knob domain of the fiber protein. 3, 4 This knowledge has directed several strategies for adenoviral vector targeting by genetic modification of the viral capsid. Peptide motifs with receptor binding specificity have been incorporated into the fiber protein by extension of the carboxy terminus of the fiber [5] [6] [7] [8] Correspondence: VW van ligands, a Myc-epitope and a 6His-tag, were attached via a flexible linker peptide. The targeted knobless fiber molecules were properly expressed and imported into the nucleus of adenovirus packaging cells, where they were incorporated as functional trimers into the adenovirus capsid. Both ligands were exposed on the surface of the virion and were available for specific binding to their target molecules. Moreover, the knobless fibers mediated gene delivery into cells displaying receptors for the coupled ligand. Hence, these knobless fibers are prototype substrates for versatile addition of targeting ligands to generate truly targeted adenoviruses. Gene Therapy (2000) 7, 1940-1946. and by insertion into the flexible and accessible HI-loop of the fiber knob. 9, 10 These studies have confirmed the feasibility of the two approaches to generate adenoviral vectors with altered binding specificities. Importantly, Roelvink et al 11 recently ablated the native receptor-binding domain by mutating the adenovirus type 5 (Ad5) fiber knob. By combining this mutation with the HI-loop insertion strategy, they developed a truly targeted adenovirus vector. However, it appears that incorporation of targeting ligands in the fiber knob is not always compatible with proper fiber folding, resulting in loss of fiber functions. 7, 8 Deletions in the fiber knob as small as only two amino acids can result in loss of fiber trimerization, the second important function of this domain. 12, 13 Since the trimeric fashion of the fiber is essential for its incorporation in the virus particle by binding to the penton base, 12, 14 modifications that result in loss of trimerization function will prevent formation of viable viruses carrying the modified protein. Clearly, the development of chimeric fibers that impose few demands on the structure of the ligand while retaining their trimeric quaternary structure would extend the applicability of targeted adenoviruses in gene therapy.
Our approach to develop truly targeted adenoviruses is to delete the complete fiber knob and to replace it with two distinct protein moieties. The first moiety is a common oligomerization motif found in many proteins, the ␣-helical coiled-coil, 15 which serves to substitute for the fiber knob trimerization function. The second moiety is the target ligand that is coupled to the trimerization domain via a flexible linker peptide, such as to allow the two moieties to adopt their functional conformations. To test this concept, we constructed a first set of knobless fiber mutants using the ␣-helix domain from the transmembrane subunit p15E of Moloney murine leukemia virus (MoMuLV) envelope glycoprotein 16 and two mimic targeting ligands, a Myc-epitope and 6His-tag. One of the chimeric proteins described here exhibited all the functions required for its use in targeted gene delivery. It was properly incorporated into the adenovirus capsid where its carboxy-terminal 6His-and Myc-epitopes were accessible for specific binding to nickel ions and immobilized anti-Myc antibodies, respectively. Moreover, these knobless fibers mediated gene transfer into cells displaying artificial receptors for His-tagged adenoviruses. Hence, the novel knobless fiber molecules described here are prototype substrates for incorporation of cell typespecific targeting ligands to generate truly targeted adenoviruses.
Results

Construction of knobless fiber genes
Two chimeric genes encoding the entire Ad5 fiber tail and shaft domains and a trimerization domain derived from the MoMuLV envelope glycoprotein were made and were designated TSC and TSFLC, respectively ( Figure 1 ). In both molecules, Ad5 fiber sequences are included that encode Met-1 to Thr-403, where Thr-403 is the last residue of the highly conserved TLWT motif that delineates the start of the fiber knob. The trimerization domain in both genes covers the 33-residue trimeric coiled-coil from Asp-515 to Leu-547 in the MoMuLV envelope glycoprotein. 16 This domain has no known binding function of its own. In TSC, the fiber shaft and trimerization domains are separated by the sequence GlySer-Gly, in TSFLC these domains are linked via a classical (Gly 4 Ser) 3 linker commonly used in single-chain antibodies. Thus, TSC and TSFLC represent fusion proteins with a linkage between the fiber-shaft and ␣-helix domains that allows minimal or maximal folding freedom, respectively. TSC and TSFLC each have a carboxyterminal (Gly 4 Ser) 2 17 This allowed the analysis of nuclear import in E1-complementing cells in the absence of a cytopathic effect (CPE). As a control, a vector expressing the bacterial LacZ gene with C-terminal Myc/6His-peptide was used. Twenty-four hours after transfection, Myc-epitope containing proteins could be detected by immunocytochemistry allowing analysis of the intracellular localization of the chimeric proteins ( Figure 2) . As was expected, the control protein LacZmychis was detected predominantly in the cytoplasm of transfected cells. In contrast, TSCmychis and TSFLCmychis proteins accumulated in the cell nuclei, where adenovirus capsids assemble. Thus, the nuclear localization signal in the Ad5 fiber tail is functionally intact and correctly targets the knobless fiber molecules with their carboxy-terminal peptide-ligands to the cell nucleus.
Trimerization of knobless fibers and accessibility of the C-terminal tag for specific binding To produce knobless fiber-expressing adenovirus vectors on conventional 293 packaging cells 18 we cloned expression cassettes for TSCmychis and TSFLCmychis in the E1-region of an adenovirus vector also carrying an expression cassette for enhanced green fluorescent protein (GFP). The resulting vectors AdGFP-TSCmychis and AdGFP-TSFLCmychis co-express the knobless fiber variants with wild-type fibers. As a negative control, AdGFP virus with GFP as the only E1-insert was produced.
Protein lysates were prepared from adenovirus vectorinfected 293 cells and subjected to Western analysis using anti-Myc and anti-fiber knob antibodies ( Figure 3a ). This showed that TSCmychis and TSFLCmychis knobless fibers were expressed, albeit at much lower levels than the wild-type fiber. The oligomeric structure of the knobless fiber molecules was assessed by comparing their electrophoretic mobility under semi-native versus denaturing conditions. As can be seen in Figure 3a , both TSCmychis and TSFLCmychis exhibited the expected molecular weight of approximately 50 kDa. Under semi-native con- ditions, approximately 5-10% was found as oligomers, as estimated by comparing band intensities of the high molecular weight and monomeric protein species. This shows that the MoMuLV trimerization domain is functional in both knobless fiber variants. The apparent molecular weight of the knobless fiber oligomers was larger than expected for homotrimers. However, analysis of the same samples with an antibody recognizing the trimeric wild-type fiber showed that most of this protein also migrated at a larger apparent molecular weight ( Figure 3a ). This is a well-described phenomenon that can be explained by partial unfolding of the fiber tail and shaft under laboratory conditions. 19 We next investigated if the 6His-targeting ligand at the C-terminus of the knobless fiber molecules was accessible for binding. To this end, cell lysates were incubated with nickel-nitrilotriacetic acid (Ni-NTA) metal-affinity matrices. Unbound material was washed away and specifically bound 6His-containing proteins were eluted by competition with imidazol. Individual fractions were subjected to Western analysis. As can be seen in Figure 3b , TSCmychis and TSFLCmychis proteins bound to Ni-NTA matrices, confirming that their C-terminal ligand is accessible for binding.
Incorporation of knobless fibers in adenovirus capsids
To investigate if the knobless fiber molecules are incorporated in complete adenovirus capsids, high-titer virus stocks of vectors AdGFP, AdGFP-TSCmychis and AdGFP-TSFLCmychis were purified by CsCl banding and subjected to Western analysis for wild-type and knobless fiber variants ( Figure 4 ). As expected, wild-type fiber trimers were detected on the capsids of all three viruses and knobless fibers were not seen on AdGFP particles. TSCmychis molecules were only inefficiently copurified with intact adenovirus particles. In contrast, the knobless fiber protein TSFLCmychis was reproducibly detected on AdGFP-TSFLCmychis particles.
To corroborate the capsid incorporation of TSFLCmychis molecules further, we investigated if functional AdGFP-TSFLCmychis viruses could bind with specificity to mimic receptors for the knobless fiber molecule. Accessibility of the 6His-tag on the virus capsid was tested by binding the virus to Ni-NTA beads. Elution of virus particles at increasing stringency of imidazol competition was quantified by measuring the functional GFP-vector titer (Figure 5a ). The wild-type fiber-expressing AdGFP virus was gradually washed out upon subsequent incubation steps, indicating that as expected it did not bind to Ni-NTA with specificity. In contrast, approximately 9.5% and 1.3% of the total recovered AdGFP-TSFLCmychis virus was found in the 50 mm and 250 mm imidazol elution fractions, respectively. In addition, full-length viral DNA could be isolated from the 250 mm fraction and visualized on EtBr-stained agarose gel (not shown). Hence, intact infectious AdGFPTSFLCmychis viral particles bound to Ni-NTA with high affinity via their 6His-tagged knobless fibers.
We also tested functional exposure of the Myc-tag on the virus capsid. To this end, AdGFP or AdGFPTSFLCmychis virus was allowed to bind to immobilized anti-Myc antibody or to anti-fiber knob antibody as a control. Target cells were exposed to the bound virus and GFP-vector titers were measured (Figure 5b ). Both viruses bound efficiently to the anti-fiber knob antibody Taken together, these findings explicitly demonstrate that the TSFLCmychis knobless fiber is incorporated in complete adenovirus vector capsids and exposes both the 6His-tag and the Myc-epitope for specific binding. The relative incorporation of knobless fibers compared with wild-type fibers was low. This is most probably a reflection of the relative abundance of the two fiber species in the packaging cells. 20 Hence, these cells can be used to test the ability of 6His-tagged knobless fibers to function as primary binding molecules for CAR-independent adenovirus-mediated gene transfer.
293.HissFv.rec cells were infected with AdGFP or AdGFP-TSFLCmychis vectors at various MOI and GFP expression was measured the next day ( Figure 6 ). To discriminate between wild-type and targeted infection, the alternative fiber-receptor interactions were blocked with neutralizing anti-fiber knob and anti-Myc antibodies, respectively. When the CAR-binding site on the wildtype fiber was blocked with anti-fiber knob antibody, gene transfer by AdGFP was efficiently inhibited to approximately 2% background infection. In contrast, depending on the MOI, AdGFP-TSFLCmychis virus exhibited 6-12% residual gene transfer in the presence of the anti-fiber knob antibody. Thus, part of the gene transfer by AdGFP-TSFLCmychis vector was wild-type fiberindependent. To confirm that this gene transfer was mediated by the TSFLCmychis knobless fiber, we added an anti-Myc antibody that binds to the carboxy terminus of the knobless fiber. This significantly reduced the gene delivery by AdGFP-TSFLCmychis vector, whereas it had no effect on the gene transfer by AdGFP. Hence, the TSFLCmychis knobless fibers on the AdGFPTSFLCmychis capsid mediate targeted gene transfer through binding of their carboxy-terminal peptide to cell surface receptors.
Figure 6 Knobless fiber-mediated gene transfer into cells displaying an artificial receptor. 293.HissFv.rec cells were subjected to infection with AdGFP or AdGFP-TSFLCmychis at MOI of 30, 100 or 300 particles per cell. Gene transfer was quantified by GFP fluorescence measurement. Wild-type fiber-dependent gene transfer was blocked with anti-fiber knob MoAb, knobless fiber-mediated gene transfer was blocked with anti-Myc MoAb. Results are given as average percent GFP expressing cells ± s.d. from a representative experiment performed in triplicate. Open bars, unblocked control infections; black bars, with anti-fiber knob MoAb; gray bars, with anti-fiber knob MoAb and anti-Myc MoAb. Relative percentage transduced cells in the presence of neutralizing anti-fiber knob MoAb compared with unblocked controls is indicated above the corresponding bars.
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Discussion
Genetic modification of adenovirus capsid proteins to target new cell surface receptors is a potentially efficient way to overcome the promiscuous tropism of wild-type adenovirus vectors. The key role of the fiber knob in the adenovirus infection pathway makes this domain a rational target for such an endeavor. However, little is known about the structural requirements for successful ligand incorporation into the complex fiber knob domain. 21 The currently available data suggest that both the carboxy-terminal extension and the HI-loop insertion strategies allow inserts that are either very small or exhibit a high degree of protein flexibility. Here, we report on the generation of a new class of chimeric fibers in which the knob is replaced by a much less complex structure that complements for the trimerization function of the knob, but that is completely devoid of its wild-type binding property. To this end, we selected the trimeric ␣-helical coiled-coil that is found in the extraviral portion of the p15E envelope protein of MoMuLV 16 and made two knobless fiber variants that differed only in the nature of the peptide linkage between the fiber shaft and trimerization domain. Upon expression in adenovirus packaging cells, both knobless fibers with their peptidetags properly accumulated in the cell nucleus. Furthermore, the two chimeric fibers formed oligomers. In different independent experiments performed, however, the efficiency of trimerization detected on semi-native gels varied considerably and was sometimes even undetectable. We attribute this to a rather weak stability of the molecules under laboratory conditions, which was not entirely unexpected, because p15E coiled-coils have a low thermostability. 22 In any event, the efficiency of trimerization was sufficient for incorporation of the chimeric fibers into the viral capsid. Several independent lines of evidence explicitly demonstrated that the TSFLCmychis knobless fiber variant was incorporated in complete and functional adenovirus vectors and exposed both its carboxy-terminal tags for specific binding. Capsid incorporation of TSCmychis molecules was much less efficient, suggesting that flexibility of the linkage between the fiber shaft and trimerization domain is important. This was a surprising observation, because trimerization and nuclear import efficiencies of the two variants seemed comparable. In addition, recent knowledge on the structure of the fiber shaft suggest that residues 393-398 that were included near to the linkage site in both knobless fiber variants already form a flexible linker. 23 Importantly, TSFLCmychis knobless fibers mediated CAR-independent gene transfer into cells displaying an artificial receptor for His-tagged adenoviruses. Thus, TSFLCmychis molecules were functional in providing primary attachment to alternative cell surface receptors. The efficiency of targeted gene transfer reached approximately 10% of wild-type fiber-mediated transduction. Since the virus binding studies had indicated that AdGFP-TSFLCmychis particles carried only few TSFLCmychis molecules compared with wild-type fibers, we may conclude that TSFLCmychis knobless fibermediated gene delivery is very efficient.
In conclusion, the TSFLC knobless fiber variant exhibited all functions required for its use in truly targeted gene transfer. It is therefore a prototype substrate to derive targeted adenovirus vectors for a variety of cell types that are important targets for gene therapy. To determine the true value of this approach vectors lacking wild-type fibers will have to be made. For this purpose, it is of note that both carboxy-terminal peptide tags of the knobless fiber were accessible for functional binding. This will allow the incorporation of a cell type-specific binding ligand in place of the Myc-epitope, while the 6His-tag can be employed for vector propagation on 293.HissFv.rec cells. Such completely knobless virus particles may perhaps encounter similar limitations as have been observed with completely fiberless particles. 24, 25 As yet unidentified domains of the fiber have been shown to play a role in particle maturation 24, 26 and intracellular trafficking. 27 If either of these functions is mediated by the fiber knob, completely knobless fiber particles may exhibit reduced infectivity. Finally, the current generation of knobless fibers may be further improved by enhancing their thermostability. To this end, teachings on structural design of trimeric coiled-coils are at hand. 28, 29 The stability of the current generation of chimeric fibers was shown to be sufficient for incorporation of peptide targeting-ligands, but a better stability could perhaps become important when more complex ligands, such as single-chain antibodies, are added.
Materials and methods
Construction of recombinant plasmids and adenoviral vectors
The knobless Ad5 fiber genes TSC and TSFLC were constructed using PCR techniques. To construct TSC, Ad5 sequences 31042-32250 were amplified using primers Tfor (5′-CTAATACGACTCACTATAGGCTCGAgccaccAT-GAAGCGCGCAAGACCGTC-3′) and CS-rev (5′-CATC TCCGGAACCGGTCCACAAAGTTAGCTTATC-3′). Tfor contains a XhoI site (underlined) and sequences fulfilling the Kozak consensus (small case) upstream of the Ad5 nt 31042-31061. CS-rev contains the antisense sequences of MoMuLV nt 7316-7319, three codons for Gly-Ser-Gly (bold), and Ad5 nt 32230-32250. The MoMuLV p15E helix was amplified using primers TC-for (5′-GTGGACCGGTTCCGGAGATGATCTCAGGGAGGT TGA-3′) and C-rev (5′-GCTAGGATCCTCCACCTCC GGAACCTCCCCCTCCTTCTTTTAGAAATAAC-3′). TC -for contains Ad5 nt 32244-32250, codons for Gly-Ser-Gly (bold) and MoMuLV nt 7316-7335. Antisense primer Crev contains codons for (Gly 4 -Ser) 2 (bold) including a restriction site for BamHI (underlined) and MoMuLV nt 7414-7435 (the first two Gly residues of the flexible linker are from the MoMuLV envelope). Next, both PCR products were mixed and amplified in an assembly PCR with sense primer T-for and antisense primer XFL-rev (5′-GCTCTAGAGCTAGGATCCTCCACCTCC-3′), containing a XbaI site (underlined). To construct TSFLC, Ad5 nt 31042-32250 were amplified using primers T-for and FLSrev(5′-GCTATCCTCCGGAACCGCCTCCACCGGTCCAC AAAGTTAGCTTATC-3′). FLS-rev contains the antisense sequences of Gly 4 -Ser-Gly 2 (bold) including a BspEI site (underlined), and Ad5 nt 32230-32250. The MoMuLV p15E helix was amplified using primers FLC-for (5′-GGTTCCGGAGGAGGAGGATCAGGTGGTGGTGG ATCAGATGATCTCAGGGAGGTTGA-3′) and C-rev. FLC-for contains codons for Gly-Ser-(Gly 4 Ser) 2 (bold) including a BspEI site, and MoMuLV nt 7316-7335. Both PCR products were (partially) digested with BspEI, mixed, ligated, and amplified using primers T-for and XFL-rev.
TSC and TSFLC were cloned into pcDNA3 vector (Invitrogen, San Diego, CA, USA) using the flanking XhoI and XbaI sites, yielding constructs pCMV-TSC and pCMV-TSFLC, respectively. Correct construction of the fusion genes was confirmed by sequencing. pCMVTSCmychis and pCMV-TSFLCmychis were made by replacing the NotI-BamHI fragment from pcDNA3.1 (−)/Myc-His/LacZ (Invitrogen) with the NotI-BamHI fragment from pCMV-TSC or pCMV-TSFLC. In the ORF of pCMV-TSCmychis and pCMV-TSFLCmychis the Cterminal (G 4 S) 2 linker is followed by the 29 amino acid sequence ELGTKLGPEQKLISEEDLNSAVDHHHHHH, where the Myc-epitope and 6His-tag are underlined.
The Ad2 tripartite leader (TPL) sequence was amplified from pMad5 30 using primers X-TPL (5′-TGCTCTA-GACTCTCTTCCGCATCGCTG-3′), containing a XbaI site (underlined), and TPL-E (5′-CAGGAATTCTTGC GACTGTGACTGGTTAG-3′), with an EcoRI site (underlined). The XbaI and XhoI (TPL nt 172) digested PCR product was inserted into XbaI/XhoI digested pCMV-TSCmychis or pCMV-TSFLCmychis, creating pCMVtpl-TSCmychis and pCMVtpl-TSFLCmychis, respectively.
The Ad2 major late promoter (MLP) and TPL were amplified from pMad5 using primers N-MLP (5′-CTAA-GAATGCGGCCGCGAGCGGTGTTCCGCGGTC-3′), containing a NotI site (underlined) and TPL-E. The PCR product was NotI/EcoRI (blunt) inserted into pBluescript II SK(−) (Stratagene, La Jolla, CA, USA) upstream of the XhoI (blunt)/PmeI fragment of pCMVtpl-TSCmychis or pCMVtpl-TSFLCmychis and the BamHI (blunt)/HindIII SV40-pA fragment from pTet-Off (Clontech, Palo Alto, CA, USA). The correct sequence of the MLP-TPL PCR product was confirmed. The NotI-ClaI inserts were isolated and the ClaI sites were made blunt-end. These fragments were cloned into pAdTrack 31 digested with NotI/KpnI (blunt), giving constructs pAdTrackMLPTSCmychis and pAdTrackMLP-TSFLCmychis, respectively.
Adenovirus vector production
Recombinant adenoviruses were produced by homologous recombination in 293 cells. 18 Adenovirus backbone plasmid pAdEasy-1 31 was digested with PacI and cotransfected together with PacI/PmeI-digested pAdTrack, pAdTrackMLP-TSCmychis or pAdTrackMLP-TSFLCmychis by the Lipofectamine PLUS (Life Technologies, Paisley, UK) method according to the manufacturer's guidelines. Virus was prepared and further expanded on 293 cells using standard procedures.
Purified virus stocks were prepared by two rounds of CsCl banding and dialysis against 10 mm Hepes pH 7.4, 10% glycerol, 1 mm MgCl (storage buffer; SB) and were stored at −80°C until use. Virus identity was confirmed by PCR analysis. Virus particle titers were determined by OD260 measurement after lysis in PBS, 1% SDS, 1 mm EDTA at 55°C. Functional titers in infectious units were determined by end-point dilution infection on 293.HissFv.rec cells 20 and detecting GFP-expressing cells 6 days after infection. The absence of replication-competent adenovirus was confirmed by infection of A549 (ATCC No. CCL-185) cells.
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Analysis of knobless fiber expression Transfection on 911 cells 17 was performed using Lipofectamine PLUS reagent (Life Technologies) according to the manufacturer's instructions. Expression analysis by immunocytochemistry was performed at 24 h after transfection, using anti-Myc MoAb 9E10, 32 RbaMIgG-AP conjugate (Dako, Glostrup, Denmark) and BCIP/NBT substrate (Dako). Cells were counterstained with nuclear fast red.
For immunoblot analysis of adenovirus vector-infected 293 cells, cells in full CPE were harvested, washed in PBS, and lysed by four freeze-thaw cycles and three times 10 s sonification. Western samples were prepared by adding 2 volumes Laemmli loading buffer with 2% SDS, 5% ␤-mercaptoethanol and 5 min heating at 95°C (denaturing condition) or a modified loading buffer with 0.2% SDS and lacking ␤-mercaptoethanol, without heating (seminative condition). Samples were separated by 7.5% SDS-PAGE and transferred to PVDF membrane (Sequiblot; Bio-Rad, Hercules, CA, USA). Immunoblots were processed according to standard procedures, using anti-Myc MoAb 9E10 or anti-fiber knob MoAb 1D6.14, 33 RbaMIgG-HRPO conjugate (Dako) and Lumilight PLUS chemiluminescence detection reagent (Boehringer Mannheim, Mannheim, Germany). Fibers on adenovirus particles were analyzed under semi-native conditions as described above for cell lysates, starting from CsCl purified virus stocks in SB.
Ni-NTA purification of His-tagged proteins and viruses Cell lysates were prepared from adenovirus vectorinfected 293 cells as described above and cleared by centrifugation. Ni-NTA Superflow resin slurry (Qiagen, Hilden, Germany) equilibrated in PBS with 300 mm NaCl (PBS-300) and 5 mm imidazol was added to reach 10% v/v beads. After 1 h incubation at 4°C, Ni-NTA resin was spun down and the unbound material was harvested. The beads were washed twice with 3 volumes PBS-300/5 mm imidazol (discarded) and once with 3 volumes PBS-300/30 mm imidazol. Finally, specifically bound material was eluted by incubation with 3 volumes PBS-300/300 mm imidazol. The eluted proteins were concentrated using Ultrafree-0.5 centrifugal filters with Biomax-10 membrane (Millipore, Bedford, MA, USA) according to the manufacturer's instructions.
Virus particles (10 12 ) in SB were mixed with 0.1 volume Ni-NTA beads equilibrated in SB and incubated for 5 h at 4°C by end-over-end rotation. Beads were sedimented by gravity on ice and unbound material was aspirated. Beads were washed twice with 9 volumes SB/5 mm imidazol, twice with 9 volumes SB/50 mm imidazol and once with 9 volumes SB/250 mm imidazol. The unbound fraction and first-step elutions at 5 mm, 50 mm, and 250 mm imidazol were kept for analysis.
Antibody-mediated virus binding assay
Ninety-six-well Microlon 200 ELISA plates (Greiner, Frickenhausen, Germany) were coated with 10 g/ml RbaMIgG MoAb (Dako) in PBS for 2 h at 37°C. After two washes with PBS, plates were incubated for 1.5 h at 37°C with PBS/1% BSA as a negative control or with 1 g/ml anti-fiber knob MoAb 1D6.14 or anti-Myc MoAb 9E10 in PBS/1% BSA. After three washes with PBS, limiting dilution particle titrations of CsCl-purified virus were made in triplicate in DMEM/F12 medium (Life Technologies) with 2% fetal bovine serum (FBS) and allowed to bind for 1 h at 37°C. Unbound virus was removed by five washes with PBS. Next, 293.HissFv.rec cells in DMEM/F12 medium with 10% FBS were seeded into the wells. After overnight culture at 37°C, cells were harvested, washed in PBS, fixated in PBS with 2.5% formaldehyde and analyzed for GFP fluorescence on a FACScan (Becton Dickinson, San Jose, CA, USA) according to standard procedures. Titer of functional virus bound was calculated according to the following equation: % GFPexpressing cells x number of cells seeded × virus dilution.
Targeted virus infection assay 293.HissFv.rec cells were seeded at 1 × 10 5 cells per well in 24-well tissue culture plates 24 h before infection. Virus was diluted in triplicate in DMEM/F12 with 1% FBS with or without 50 g/ml 1D6.14 MoAb and/or 25 g/ml 9E10 MoAb, and incubated at RT for 30 min. Next, the virus/antibody mixtures were added to the cells at MOI ranging from 30 to 300 particles per cell. The virus was allowed to bind for 30 min at RT, following which the medium was replaced by DMEM/F12 with 10% FBS. After 24 h incubation at 37°C, cells were harvested and analyzed for GFP expression on a FACScan according to standard procedures.
